LifeVantage (LFVN) Projected to Post Earnings on Wednesday

LifeVantage (NASDAQ:LFVNGet Free Report) will likely be releasing its earnings data after the market closes on Wednesday, February 5th. Analysts expect LifeVantage to post earnings of $0.13 per share and revenue of $67.41 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

LifeVantage (NASDAQ:LFVNGet Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $47.21 million for the quarter. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%.

LifeVantage Trading Up 1.0 %

Shares of LFVN opened at $21.73 on Wednesday. The firm has a market cap of $272.17 million, a PE ratio of 67.91 and a beta of 0.82. The firm has a fifty day simple moving average of $18.12 and a two-hundred day simple moving average of $13.04. LifeVantage has a 1-year low of $5.22 and a 1-year high of $27.38.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on LFVN. Craig Hallum began coverage on shares of LifeVantage in a research note on Tuesday, January 14th. They set a “buy” rating and a $35.00 target price for the company. Lake Street Capital began coverage on shares of LifeVantage in a research note on Thursday, December 19th. They set a “buy” rating and a $26.00 target price for the company.

View Our Latest Research Report on LFVN

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Recommended Stories

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.